Analysis | Metabolite Name | Measured Value | Units | Ethnicity | Gender | Group |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.205 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.215 | pmol/gram | Hispanic | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.309 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.329 | pmol/gram | Hispanic | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.351 | pmol/gram | Caucasian | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.358 | pmol/gram | Caucasian | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.592 | pmol/gram | Hispanic | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.931 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.943 | pmol/gram | Caucasian | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 0.968 | pmol/gram | Hispanic | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 1.19 | pmol/gram | Hispanic | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 1.21 | pmol/gram | Caucasian | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 1.27 | pmol/gram | Caucasian | Male | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 1.36 | pmol/gram | Hispanic | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 1.58 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 1.81 | pmol/gram | Caucasian | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 2.06 | pmol/gram | Caucasian | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 2.28 | pmol/gram | Hispanic | Male | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 2.47 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 2.73 | pmol/gram | Hispanic | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 3.18 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 3.51 | pmol/gram | Hispanic | Female | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 3.91 | pmol/gram | Hispanic | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 4.26 | pmol/gram | Hispanic | Male | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 4.33 | pmol/gram | Caucasian | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 4.7 | pmol/gram | Hispanic | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 5.01 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 5.46 | pmol/gram | Hispanic | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 5.55 | pmol/gram | Caucasian | Male | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 5.61 | pmol/gram | Hispanic | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 6.12 | pmol/gram | Caucasian | Male | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 6.31 | pmol/gram | Caucasian | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 6.49 | pmol/gram | Caucasian | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 10.6 | pmol/gram | Hispanic | Female | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 11.4 | pmol/gram | Hispanic | Male | NAFLD |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | 18.6 | pmol/gram | Caucasian | Male | Healthy Control |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | pmol/gram | Caucasian | Female | Healthy Control | |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | pmol/gram | Caucasian | Male | Healthy Control | |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | pmol/gram | Caucasian | Male | NAFLD | |
Reversed phase NEGATIVE ION MODE/Eicosanoids | PGF2a | pmol/gram | Hispanic | Female | NAFLD |